The Union Health Ministry has amended the Drugs and Cosmetics Rules, 1945, to tighten regulations on the sale of cough syrups.
Cough syrups have been removed from Schedule K, which previously granted exemptions for their sale.
This change mandates that cough syrups can now only be sold through duly licensed pharmacies and require a doctor's prescription.
The amendment follows incidents of child deaths, including 22 in Madhya Pradesh's Chhindwara district, linked to allegedly contaminated cough syrups.
Detailed Insights:
Prior to the amendment, Entry No. 13 of Schedule K permitted the sale of cough syrups in general stores in villages with a population of less than 1,000, without requiring full compliance with retail sale licensing provisions.
The removal of "syrups" from this entry means the exemption is no longer available, subjecting cough syrups to stricter regulatory oversight.
The decision aims to curb misuse, prevent accidental poisoning, and enhance control over the quality and safety of syrup formulations.
This regulatory change applies to all syrup-based medicines, including certain Ayurvedic and Homoeopathic formulations, which now require a prescription.
The Drug Consultative Committee (DCC) had approved the proposal after reviewing issues related to toxic contaminants like Diethylene Glycol (DEG) and Ethylene Glycol (EG) in syrups.
Key Concepts Involved:
Union Health Ministry: The central government body responsible for health policy and regulation in India.
Drugs and Cosmetics Act, 1940: The primary legislation that regulates the import, manufacture, distribution, and sale of drugs and cosmetics in India.
Drugs and Cosmetics Rules, 1945: Rules framed under the Drugs and Cosmetics Act, 1940, detailing specific provisions for drug regulation.
Schedule K: A schedule within the Drugs and Cosmetics Rules, 1945, that lists categories of drugs exempted from certain provisions of the Act and Rules, often to improve accessibility.